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Evidence is starting to emerge indicating that tumorigenesis in metazoans involves a soma-to-germline transition, which may
contribute to the acquisition of neoplastic characteristics. Here, we have meta-analyzed gene expression profiles of the human
orthologs of Drosophila melanogaster germline genes that are ectopically expressed in l(3)mbt brain tumors using gene
expression datasets derived from a large cohort of human tumors. We find these germline genes, some of which drive onco-
genesis in D. melanogaster, are similarly ectopically activated in a wide range of human cancers. Some of these genes nor-
mally have expression restricted to the germline, making them of particular clinical interest. Importantly, these analyses
provide additional support to the emerging model that proposes a soma-to-germline transition is a general hallmark of a wide
range of human tumors. This has implications for our understanding of human oncogenesis and the development of new ther-
apeutic and biomarker targets with clinical potential.
Neoplastic disease occurs when cells acquire altered biological
capabilities, ultimately enabling them to form potentially
lethal tumor colonies capable of evading intrinsic and extrin-
sic tumor suppressing activities.1 However, individual tumors
are a complex, mixed population of cells subjected to
ongoing genetic and epigenetic changes and it seems likely
that speciﬁc subgroups of cells within the tumor make differ-
ential contributions to the tumor hallmarks.2,3 Deﬁning the
acquired changes of tumors on a whole tumor scale provides
a global insight into the characteristics of the tumor as a
deﬁned biological entity and increases the likelihood of iden-
tifying clinically important biomarkers. Recent work from a
range of organisms has revealed that tumors may acquire a
more germline-like state.4–9 Moreover, it has been demon-
strated that the germline gene expression has the potential to
be oncogenic in Drosophila melanogaster4 and is associated
with clinically more aggressive tumors in humans.8 Janic
et al. recently demonstrated that l(3)mbt tumors in D. mela-
nogaster ectopically expressed a broad range of germline
genes, with up to a quarter of ectopically expressed genes
being associated with a known germline function.4 Inactiva-
tion of some of these germline genes results in suppression
of tumorigenesis, indicating that they play an essential role in
tumor development.4 l(3)mbt encodes a transcriptional
repressor component of the dREAM-MMB and LINT com-
plexes10,11 and inactivation of other components of the
dREAM-MMB complex also results in germline gene expres-
sion12; however, some mutations of dREAM-MMB compo-
nent genes do not result in laval brain tumors suggesting that
the LINT complex plays an important tumor suppressing
function.10 A similar activation of a germline-like
transcriptional programme has been observed in Caenorhab-
ditis elegans strains mutated for dREAM-MMB related
functions, suggesting a conserved functional relationship
between tumorigenesis and germline gene expression in
metazoans.13,14
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In humans, there is a group of genes with expression
restricted to testicular cells which are also aberrantly
expressed in various tumor types, the so called cancer-testis
(CT) genes, which has led to the suggestion that a soma-to-
germline transformation may also occur in human can-
cers.5,9,15 The immunological privilege of the testis16 makes
the antigens encoded by CT genes promising candidates for a
wide range of novel immune-directed therapeutic and moni-
toring tools for clinical applications.17,18
As ectopic expression of some germline genes is required
for l(3)mbt brain tumor growth in D. melanogaster,4 it is
important to investigate the expression pattern of germline
genes in cancerous and healthy human tissues. Recently, a
novel cohort of CT genes was identiﬁed by meta-analyzing the
expression proﬁles of human orthologs of mouse meiotic
genes.19 This and other recent works8 support the proposal
that a generalized hallmark of human tumors is a soma-to-
germline transformation.9 Here, we provide further support for
this proposal by investigating the expression of the orthologs of
the D. melanogaster germline genes ectopically expressed in
l(3)mbt tumors in human cancerous and normal tissue.4 We
meta-analyzed a range of human tumor proﬁles19,20 to demon-
strate that most of the D. melanogaster genes for which human
orthologs were identiﬁed were also up-regulated in human can-
cers. Moreover, 19 of these have normal expression restricted
to tissues residing in immunological privilege (brain, placenta
and testis) indicating they may be CT genes and thus may
make excellent cancer-speciﬁc therapeutic targets.
Material and Methods
Human homologs of the Drosophila germline genes
We assigned the 49 germline genes ectopically expressed in
l(3)mbt tumors in D. melanogaster (3) to their human ortho-
logs using the databases Flybase,21 Homologene22 and
Ensembl23 as well as literature search (Supporting Information
Table S1). We could identify human orthologs for 28 genes,
resulting in 46 human genes due to human paralogs. Enriched
gene ontology (GO) terms for the human homologs were
determined using the functional annotation tool DAVID.24
EST meta-analysis
Forty-three of the forty-six human homologs could be mapped
to Unigene IDs. A comprehensive EST expression proﬁle across
36 tissues was constructed for these genes based on a method-
ology developed for a previous study.19 Brieﬂy, all ESTs of a
given tissue type t available from the Unigene database (Unig-
ene Build #230)25 were merged to a meta-library, excluding
ESTs from normalized and subtracted cDNA libraries or deriv-
ing from uncharacterized, mixed or embryonic/fetal tissues.
Meta-libraries with an EST count below 10,000 were excluded
to assure signiﬁcance, resulting in cancer and normal meta-
libraries for 36 tissue types. For each Unigene cluster the global
expression proﬁle in cancerous and healthy tissues is computed
by EST counting, following the concept of the Unigene EST
proﬁles.25 The expression proﬁles in cancerous and healthy tis-
sues were normalized by calculating the transcripts per million
(tpmt;c5mt;c=nt  106), where mt,c is the number of ESTs for a
given cluster c and for a given tissue type t, and nt is the total
number of ESTs for that given tissue type t. Genes with expres-
sion restricted to the testis, brain and placenta as well as lim-
ited expression in one or two tissues were selected to be testis-
or testis/brain restricted. The signiﬁcance of upregulation in
cancer was calculated using the Fisher’s exact test.26 Genes with
a p value< 0.05 or with expression in cancerous meta-libraries
but not in the corresponding healthy meta-libraries were con-
sidered to be upregulated or ectopically expressed, respectively,
in these cancer types. To visualize the analysis results, Circos
plots27 and bar charts were created.
Single and meta-analysis of microarray studies
Forty-one of the forty-six human homologs could be mapped
to Affymetrix array indices for the HG-U133 Plus 2 array
and thus could be evaluated for their differential expression
in 13 cancer types by means of a meta-analysis approach
developed for a previous study.19,20 Genes with a meta-log
twofold change >1 or a conﬁdence interval that does not
span 0, and a meta-p value <0.05 were considered as poten-
tially signiﬁcant. To visualize the analysis results, Circos
plots27 and forest plots28 were created.
Implementation
The meta-analysis pipelines described above were implemented
using: R 2.12.1 (available at: http://www.cran. r-project.org)29;
the Bioconductor package (available at: http://www.bioconduc-
tor.org)30; MySQL 5.0.77 (available at: http://www.mysql.com)
and Perl 5.8.8 (available at: http://www.perl.org).
Results
Identification of human homologs of the Drosophila
l(3)mbt tumor up-regulated germline genes
Janic et al. reported 49 Drosophila germline genes to be over-
expressed in l(3)mbt tumors.4 We could map 28 of these
What’s new?
Although individual tumors are a complex mosaic of cells, subject to ongoing genetic and epigenetic change, evidence sug-
gests that a general hallmark of human cancer is the development of tumors from a soma-to-germline transition. This meta-
analysis supports that idea, revealing that human genes that are orthologues of the oncogenic germline drivers of brain
tumors in Drosophila melanogaster are activated in a wide range of human cancers. The findings have implications for the
understanding of cancer and for the development of new therapeutic and diagnostic tools.
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genes to their human orthologs, resulting in expansion to 46
human genes due to human paralogs (Table 1 and Support-
ing Information Table S1). In support of this, the top
enriched gene ontology (GO) terms show that many are
linked to germline functions in humans as well, with 56.5%
(26/46) being associated with germline functions (Table 1
and Supporting Information Table S2).
EST meta-analysis
We investigated 43 human orthologs for their cancer expres-
sion, cancer marker potential and tissue-speciﬁcity based on
the construction of a comprehensive expression proﬁle (of
the original 46 human orthologs identiﬁed 3 could not be
mapped to Unigene IDs and so only 43 were taken forward).
Brieﬂy, if genes show expression only in immunologically
privileged tissues and in not more than two other healthy tis-
sues, the genes are considered as testis- or testis/brain
restricted. Nineteen genes exhibit such an expression proﬁle
(Supporting Information Table S3) including the previously
characterized CT genes, SYCP1,31 TDRD132 and PIWIL2.33
MAEL, also a previously characterized CT gene,34 shows
expression in three normal tissues. Furthermore, 12 of these
19 genes exhibit ectopic cancer expression in at least one
cancer type; for example, the gene C16orf73 is expressed in
testis, brain and placenta as well as ectopically expressed in
melanoma and sarcomas of the bone and of the connective
tissue (Fig. 1; further examples are given in Supporting Infor-
mation Fig. S1). In total, 35 of 43 human homologs exhibit
ectopic expression or are up-regulated in a wide range of
cancers (Fig. 2 and Supporting Information Fig. S2), consist-
ent with an extensive soma-to-germline transformation in a
range of tumor types.
Single and meta-analysis of microarray studies
We evaluated the differential expression for 41 human ortho-
logs (ﬁve genes are not present on the arrays) based on a
Table 1. Human orthologs of 28 Drosophila germline genes overex-
pressed in l(3)mbt tumors1
Drosophila gene Human orthologs
AGO3 PIWIL4, PIWIL2, PIWIL3, PIWIL1
aub PIWIL4, PIWIL2, PIWIL3, PIWIL1
bgcn YTHDC2
BicC BICC1
bol DAZ1, DAZ2, DAZ3, DAZ4, BOLL, DAZL
c(3)G SYCP1
dhd TXN, TXNL1
fus ESRP1, ESRP2
hdm C16orf732
krimp TDRD1, RNF17
loki CHEK2
mael MAEL
mia TAF6, TAF6L
mre11 MRE11A
nos NANOS1, NANOS3, NANOS2
orb CPEB12, RP11-152F13.10
ovo OVOL1, OVOL2, OVOL3
piwi PIWIL4, PIWIL2, PIWIL3, PIWIL1
png NEK1, NEK5, NEK3
RpS19b RPS19
RpS5b RPS5
shu FKBP6
spn-E TDRD92
tej TDRD7
vasa DDX4
vis TXN, TXNL1, TGIF2LX, TGIF2LY
zpg TGIF2
cTub37C TUBG1
Bold5human orthologs with germline GO designation (also see Sup-
porting Information Table S2). None embolden genes have GO designa-
tions that are not directly associated with germline or development
programmes (although this does not exclude them from having a germ-
line function).
1A full list of all Drosophila germline genes over expressed in l(3)mbt
tumors along with Ensemble/Flybase ID and sources is given in Sup-
porting Information Table S1.
2Human genes with germline GO terms are associated with these genes
using AmiGO (http://amigo.geneontology.org/cgi-bin/amigo/go.cgi); no
GO designations were identified by DAVID at the time of analysis (see
Supporting Information Table S2).
Figure 1. Example of a bar chart showing the integrated expression
profile of the C16orf73 gene. C16orf73 exhibits expression
restricted to the brain, placenta and testes, but is aberrantly
expressed in melanoma DNA sarcomas of the bone and the con-
nective tissue. Gene expression is given as transcripts per million
(tpm). Further examples of expression profiles are given in Sup-
porting Information Figure S1.
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microarray meta-analysis approach across 13 cancer types.
Thirty-one of the forty-one human orthologs are signiﬁcantly
up-regulated in 11 distinct cancer types (Fig. 3, Supporting
Information Fig. S3 and Table S4). Nine of the nineteen tes-
tis- or testis/brain-restricted genes were found to be signiﬁ-
cantly up-regulated, in particular in ovarian and brain
cancer. For example, the gene RNF17 shows up-regulation in
ovarian, prostate and brain cancer (Supporting Information
Fig. S4 and Table S4).
Furthermore, analysis of differential expression in 80 indi-
vidual microarray studies provides evidence that even 39 of
the total 41 genes and 14 of the 19 testis- or testis/brain-
restricted are up-regulated in speciﬁc cancers (Supporting
Information Fig. S5).
Cancer expression of human germline genes
Combining the results of the EST meta-analysis of the single
microarray analysis as well as that of the microarray meta-
analysis can provide a comprehensive picture of the cancer
expression of the human germline genes investigated. In
addition to the 4 previously characterized CT genes (SYCP1,
TDRD1, MAEL and PIWIL2), 36 other germline genes show
Figure 2. Circos plot showing the gene expression in relation to the corresponding cancer types for the 43 human orthologs based on the
EST meta-analysis. Thirty-five of these forty-three human genes present in the Unigene database exhibit ectopic expression or are up-
regulated in a wide range of cancers according to the EST meta-analysis. Each connection between a gene and a cancer type indicates
found expression in cancer. The magnitude of the connection corresponds to the transcripts per million (tpm) for the given gene in a given
tissue. A Circos plot showing the EST meta-analysis for testis-restricted alone is given in Supporting Information Figure S2.
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evidence for ectopic expression or up-regulation in various
cancer types (Supporting Information Table S5). Because of
likely gene duplication events there are a number of human
paralogs to orthologs Drosophila gene, resulting in the inclu-
sion of gene families in the human analysis; for example, the
PIWIL family genes PIWIL1 and PIWIL2. Differential expres-
sion in cancer of the family member genes PIWIL3, TGIF2LY
and OVOL3 could not be evaluated, as these genes are not
present on the arrays investigated (Supporting Information
Table S5). Thus, these genes need to be further investigated
to determine their cancer expression.
New CT candidates
Fifteen genes exhibit a testis- or testis/brain-restricted expres-
sion pattern according to the EST meta-analysis as well as
showing evidence for aberrant cancer expression based on
the results of the different expression analyses (Supporting
Information Table S5). These include the three known CT
genes SYCP1, TDRD1 and PIWIL2 and mainly members of
the gene families mentioned above. A further four genes
(NANOS2, PIWIL3, TGIF2LX and NEK5) have a testis- or
testis/brain-restricted expression proﬁle, but no cancer
expression could be detected to date.
Figure 3. Circos plot showing the meta-change in gene expression in relation to corresponding cancer types for the 41 human homologs
based on the microarray meta-analysis. Thirty-one of these forty-one human genes covered by the arrays exhibit an up-regulation according
to the microarray meta-analysis. Each connection between a gene and a cancer type indicates a statistically significant mean up-regulation
for that cancer type derived from a number of combined array studies for cancer versus normal tissue. The weight of the connection corre-
sponds to the magnitude of the meta-change in gene expression. A Circos plot showing the microarray meta-analysis for testis-restricted
alone is given in Supporting Information Figure S3.
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Discussion
Expression of human germline genes in cancers
Here, we show that the Drosophila germline genes ectopically
expressed in l(3)mbt tumors are also aberrantly expressed or
overexpressed in a wide range of human cancers. Fifteen of
these genes also exhibit a testis- or testis/brain-restricted
expression pattern, which makes them potential CT gene
candidates. We have used the results of the EST meta-
analysis, of the single microarray analysis as well as of the
microarray meta-analysis to construct a comprehensive pic-
ture of their expression. Combining studies can enhance reli-
ability and generalizability of the results, as meta-analyses are
generally accepted to compute a more precise and reliable
estimate of gene expression.35
Although most known CT genes are encoded on the X
chromosome,15 most of the 15 CT gene candidates are auto-
somally encoded. In general, almost all human homologs we
have investigated are autosomally encoded (Supporting Infor-
mation Table S5). We found mainly germline gene family
members to be ectopically expressed or up-regulated in can-
cer. Most of these family members are thought to be involved
in meiosis or spermatogenesis such as the NANOS or DAZ
family genes.36,37 At least 11 genes produce proteins that are
associated with meiosis, and a total of 14 gene products may
function in spermatogenesis (Supporting Information Table
S2). Consistent with this, we have recently identiﬁed a cohort
of CT candidate genes involved in meiotic spermatogenesis
by analyzing the expression of human homologs of meiotic
mouse genes, many of which are also autosomally encoded.19
We also found several genes to be down-regulated in a
range of cancer types such as the genes CPEB1 and ESRP1.
This is not surprising as several genes are not germline-
speciﬁc. Here, the loss of their functions could drive the
malignant state of cancer cells. CPEB1 and ESRP1, for exam-
ple, are both potential tumor suppressor genes.38,39
A soma-to-germline transformation in human cancers
Tumorigenesis in humans may involve a soma-to-germline
transformation, which in turn may support the acquisition of
malignant attributes such as rapid proliferation, undifferenti-
ated phenotype and immortality. Such transformations have
not only been reported in Drosophila with mutations in
l(3)mbt (dREAM-MMB/LINT pathways),4,10,12 but also in C.
elegans strains with mutations in the homologs of the dREAM-
MMB complex14 and in members of the nucleosome remodel-
ing and histone deacetylase (NuRD) complex,13 which are
chromatin regulators of the SynMuv pathway.40,41 Many Syn-
Muv proteins and their antagonistic SynMuv suppressor pro-
teins have been associated with histone modiﬁcation,
nucleosome remodeling as well as transcriptional repression
and play a role in germline-soma distinction.40,42–44 These data
suggest that genes functioning in particular in the retinoblas-
toma pathway are responsible for repression of germline
expression in somatic cells and thus mutations in this pathway
may initialize a soma-to-germline transformation. Many of
these genes are conserved in mammals40 and the human reti-
noblastoma pathway is disrupted in virtually all cancer types,
which is known to promote cellular proliferation.45,46 Few Dro-
sophila germline genes are already known orthologs of human
CT genes; for example, SYCP1 is the human homolog of the
Drosophila germline gene c(3)G.31 In human cancer, the
expression of numerous CT genes may reﬂect the occurrence
of such a soma-to-germline transformation. Also in humans, it
has been suggested that cells become altered in genes that con-
trol germline gene expression, which could lead to an induction
of a gametogenic programme in cancer.9,15 Here we provide
evidence that 40 of 46 human homologs of the Drosophila
germline genes ectopically expressed in l(3)mbt tumors are also
ectopically expressed or up-regulated in a wide range of human
cancers, not just germline tumors, which supports the proposal
that human cancer cells undergo a similar soma-to-germline
transformation. Many of the hallmarks of cancer have recently
been delineated1 and collective evidence, including that pre-
sented here, points to a soma-to-germline transformation being
a key additional hallmark of a wide range of human tumor
types.5,8,9,15,19
Soma-to-germline transformation: meiotic genes as
oncogenic drivers
The ectopic expression of a few testis-speciﬁc factors, which
act as epigenetic and transcriptional regulators, could further
drive the soma-to-germline transformation.9 The expression
of meiotic genes is tightly regulated and mostly restricted to
germline cells. The expression of meiotic genes, in particular
those with chromosome modulating potential, in mitotic cells
could lead to perturbation of the mitotic process and thus
could result in inappropriate recombination events, leading
to oncogenic changes such as translocations, aberrant chro-
mosome segregation and aneuploidy,9,15,19,47 which in turn
are hallmarks of cancer.1 Kalejs et al., for example, reported
the up-regulation of meiosis-speciﬁc genes in tumor cells,
which appears to be associated with arrested mitosis and pol-
yploidy.48 A key example of how germline genes might play
a fundamental role in oncogenesis comes from the ﬁnding
that PIWI proteins have been implicated in tumorigenesis.49
Many cellular events are controlled by small RNA molecules
and PIWI proteins regulate small germline micro RNAs
known as piRNAs.49 Quite how PIWI proteins might inﬂu-
ence tumor formation and progression has been poorly stud-
ied to date, but one key suggestion that has been postulated
proposes that PIWI proteins can contribute to the unprog-
rammed silencing of tumor suppressor genes, thus fostering
oncogenesis.49 A number of the human germline genes we
investigated here are also associated with meiosis. Not only
may ectopic expression of germline genes be important as a
key oncogenic driver, but the normal immunological privilege
of the gene products make these excellent targets for the
development of new therapeutic and clinical biomarker
strategies.
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